How B12 deficiency affects the nervous system
Vitamin B12 works with folate in chemical reactions that help maintain myelin, the insulating material around nerves. It also supports a separate reaction whose failure allows methylmalonic acid, or MMA, to accumulate. That is why MMA can help clinicians investigate B12 deficiency.
B12 deficiency can damage myelin and nerve fibers. Researchers have proposed several contributing mechanisms, including disrupted chemical reactions, altered fatty-acid metabolism and changes in the cells that support nervous tissue. The precise sequence is not completely settled, but B12’s importance to nervous-system development and function is well established. [1]
Symptoms of B12-related nerve injury
Possible symptoms include:
- Tingling, burning or numbness in the feet or hands
- Reduced sensitivity to vibration
- Difficulty sensing the position of the feet
- Poor balance, falls or an abnormal gait
- Weakness, stiffness or muscle spasms
- Cognitive or mood changes
- Visual disturbances caused by optic-nerve involvement
Severe deficiency can cause subacute combined degeneration, a condition affecting particular regions of the spinal cord.
Nerve injury can occur without anemia or macrocytosis. Treatment is therefore sometimes needed even when the blood count appears normal. If treatment is delayed, some neurological deficits can become permanent. [2]
When to seek urgent care
Prompt medical assessment is appropriate for new or worsening:
- Difficulty walking
- Significant weakness
- Rapidly spreading numbness
- Repeated falls
- Loss of bladder or bowel control
- Confusion or marked cognitive change
- Visual loss
These symptoms should not be managed solely with an over-the-counter supplement trial.
What an MTHFR variant changes
MTHFR is an enzyme involved in folate metabolism. The common variants most often discussed are C677T and A1298C.
C677T—particularly when a person has two copies—can contribute to lower folate status and higher homocysteine under some circumstances. The independent effect of A1298C is less clear.
These common variants do not ordinarily:
- Prevent the intestines from absorbing B12
- Prove that a person has B12 deficiency
- Explain neuropathy by themselves
- Make cyanocobalamin unusable
- Make methylcobalamin medically necessary
Common MTHFR variants should not be confused with rare pathogenic mutations that cause severe inherited MTHFR deficiency or homocystinuria. Those uncommon disorders require specialist metabolic or genetic care.
The CDC states that common MTHFR variants are not a reason to avoid folic acid. Folate intake generally has more influence on blood folate than the common genotype does. [3]
Why homocysteine is not enough
Homocysteine may rise because of:
- B12 deficiency
- Folate deficiency
- An MTHFR variant
- Impaired kidney function
- Hypothyroidism
- Smoking
- Certain medications or health conditions
A high homocysteine result therefore cannot identify B12-related nerve injury by itself. An MTHFR variant makes this measurement even less specific.
MMA is more closely connected to B12 metabolism and can help when serum B12 is borderline. However, MMA can also rise with impaired kidney function and with age, so it still requires clinical interpretation.
How B12 deficiency is investigated
Before treatment, clinicians may request:
- A complete blood count
- Total or active B12
- MMA
- Folate
- Homocysteine
- Kidney-function tests
- Antibodies against intrinsic factor, a stomach protein needed for normal B12 absorption, when autoimmune damage to the stomach is suspected
- Coeliac testing or other investigations for malabsorption
Blood should ideally be collected before the first B12 dose because supplements and injections can raise the measured B12 concentration.
Treatment should not be delayed, however, when there are serious or rapidly progressing neurological symptoms. NICE specifically advises starting B12 replacement without waiting for results when B12 deficiency with neurological involvement is strongly suspected.
Initial treatment when nerves are affected
Clinicians often favor B12 injections when a person has substantial neurological symptoms. Injections provide reliable delivery while the cause and severity of the deficiency are being investigated.
One commonly used UK regimen is intramuscular hydroxocobalamin at a dose of 1 milligram (1,000 micrograms) on alternate days during the initial loading phase, followed by clinical review. Treatment may continue at frequent intervals while neurological improvement is still occurring.
Other healthcare systems use cyanocobalamin injections, sometimes with daily or weekly loading followed by monthly maintenance. Exact schedules vary by country, available product, severity and underlying cause. They should be prescribed rather than reconstructed from supplement labels. [4]
High-dose oral B12 can also work because a small proportion is absorbed passively, without relying on intrinsic factor. Therapeutic oral regimens frequently use 1,000–2,000 micrograms per day. Oral treatment is most dependable when the dose is adequate and adherence is consistent.
Injections may be preferred when there is:
- Serious or progressive neurological involvement
- Uncertain adherence
- Major malabsorption
- Vomiting or inability to take tablets
- A need for rapid, reliable replacement
Long-term treatment depends on the cause
Autoimmune gastritis or pernicious anemia
Autoimmune damage can prevent normal absorption of food-bound B12. Because the underlying problem is generally irreversible, lifelong B12 replacement is usually required.
Gastric or intestinal surgery
Removal of the entire stomach or the final section of the small intestine are irreversible causes of impaired B12 absorption. Long-term replacement is normally required.
Other gastrointestinal operations may also impair absorption, but the appropriate route and duration depend on the anatomy and severity.
Dietary deficiency
A person whose diet contains little or no B12 can usually be treated with oral B12. A dependable continuing source—such as a supplement or fortified food—is needed if the dietary pattern remains unchanged.
Medication-associated deficiency
Metformin and long-term acid-suppressing medicines can contribute to B12 deficiency. Treatment may continue while the relevant medication is still required. Prescribed medicines should not be stopped without discussing the risks and alternatives with the clinician managing them.
Nitrous-oxide exposure
Nitrous oxide can inactivate B12 and cause neurological injury even when serum B12 is not obviously low. Continued exposure can undermine treatment. Suspected nitrous-oxide neurological toxicity requires prompt assessment, cessation of exposure and clinician-directed B12 replacement.
Does the form of B12 matter with MTHFR?
Methylcobalamin is a legitimate B12 form, but it is not the only one that works.
Cyanocobalamin and hydroxocobalamin can be converted into the active B12 cofactors required by cells. The effectiveness of treatment depends more on adequate dosing, reliable absorption, treatment route and correction of the underlying cause than on an “MTHFR-friendly” product claim.
Small route-comparison studies have not established a general advantage for B12 dissolved under the tongue over an adequately dosed swallowed tablet.
Folate must not replace B12 treatment
B12 and folate participate in connected metabolic pathways, but folate cannot substitute for B12.
Folate treatment can improve the anemia caused by B12 deficiency while neurological injury continues. A corrected blood count therefore does not prove that the nervous-system problem has been treated.
If both nutrients are deficient, clinicians may replace both, but B12 should be started first or at the same time. Treating suspected B12-related neurological injury with folate alone is unsafe.
The same principle applies to methylfolate, also called 5-MTHF. It may be used as a folate source in some circumstances, but it does not repair an untreated B12 deficiency.
What treatment trials tell us about nerve recovery
The trial result depends on who had symptoms at the start. A year-long study of 201 adults aged 75 or older[5] compared daily 1 mg oral B12 with placebo and corrected moderately low B12 without improving nerve function or cognition in participants who had no neurologic symptoms or anemia. That result does not answer the treatment question for symptomatic deficiency.
In contrast, a small trial in metformin-treated diabetic neuropathy[6] found that daily 1 mg methylcobalamin improved pain and several nerve measures compared with placebo. Cardiovascular autonomic tests and the clinical examination did not improve. Diabetes-related neuropathy and B12-related injury can coexist, so the cause still matters. The B12 research discussion explains the population, effect and dose-comparison evidence.
What recovery looks like
Some people begin noticing improvement within two weeks, but neurological recovery commonly takes several months. Balance problems, reduced position sense and long-standing numbness may improve more slowly.
Recovery depends on:
- How long the deficiency existed
- The severity of the neurological injury
- Whether the underlying cause has been addressed
- Whether treatment delivers enough absorbed B12
- Whether another condition is also contributing
Symptoms that persist despite adequate replacement should prompt reconsideration of the diagnosis. Other possible causes include diabetes, thyroid disease, copper deficiency, excessive supplemental vitamin B6, spinal compression and unrelated neurological disorders.
After injections, serum B12 may become very high regardless of whether every symptom has resolved. Follow-up should therefore consider walking, balance, sensation, strength and day-to-day function—not just the serum B12 number.
The bottom line
B12 deficiency can damage peripheral nerves, the optic nerve and the spinal cord, even without anemia. Early replacement offers the best chance of recovery, while prolonged deficiency can leave permanent neurological deficits.
Common MTHFR variants affect folate metabolism and can complicate the interpretation of homocysteine, but they do not usually change the basic treatment for B12 deficiency. They do not make methylcobalamin mandatory, and methylfolate cannot substitute for B12.
When neurological symptoms are significant, treatment often begins with clinician-directed B12 injections, followed by maintenance based on the underlying cause. The essential priorities are prompt replacement, adequate absorbed dosing, identification of the cause and follow-up based on neurological recovery.
Help us improve this article
Spotted an error or found a source we should consider? Tell us which part of this article needs another look and include a link if you have one. Please leave out personal health details and lab results; we can’t answer individual medical questions.
More about vitamin B12 (Cobalamin)
Explore more in nerves
Food sources & dietary alternatives
References
Corrections & updates
- Update
Updated the evidence discussion and practical guidance after editorial review.
- Update
Revised the article after editorial review, with clearer evidence explanations and practical guidance.